Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1983 1
1991 1
1999 1
2001 1
2002 1
2003 1
2006 1
2007 1
2008 1
2009 1
2010 1
2011 1
2012 2
2013 1
2014 3
2015 2
2018 2
2019 5
2020 5
2021 2
Text availability
Article attribute
Article type
Publication date

Search Results

30 results
Results by year
Filters applied: . Clear all
Page 1
Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis.
Cohen JA, Barkhof F, Comi G, Hartung HP, Khatri BO, Montalban X, Pelletier J, Capra R, Gallo P, Izquierdo G, Tiel-Wilck K, de Vera A, Jin J, Stites T, Wu S, Aradhye S, Kappos L; TRANSFORMS Study Group. Cohen JA, et al. Among authors: de vera a. N Engl J Med. 2010 Feb 4;362(5):402-15. doi: 10.1056/NEJMoa0907839. Epub 2010 Jan 20. N Engl J Med. 2010. PMID: 20089954 Free article. Clinical Trial.
Secukinumab maintains superiority over ustekinumab in clearing skin and improving quality of life in patients with moderate to severe plaque psoriasis: 52-week results from a double-blind phase 3b trial (CLARITY).
Bagel J, Blauvelt A, Nia J, Hashim P, Patekar M, de Vera A, Ahmad K, Paguet B, Xia S, Muscianisi E, Lebwohl M. Bagel J, et al. Among authors: de vera a. J Eur Acad Dermatol Venereol. 2021 Jan;35(1):135-142. doi: 10.1111/jdv.16558. Epub 2020 Jun 8. J Eur Acad Dermatol Venereol. 2021. PMID: 32365251 Free PMC article. Clinical Trial.
Secukinumab is Superior to Ustekinumab in Clearing Skin in Patients with Moderate to Severe Plaque Psoriasis (16-Week CLARITY Results).
Bagel J, Nia J, Hashim PW, Patekar M, de Vera A, Hugot S, Sheng K, Xia S, Gilloteau I, Muscianisi E, Blauvelt A, Lebwohl M. Bagel J, et al. Among authors: de vera a. Dermatol Ther (Heidelb). 2018 Dec;8(4):571-579. doi: 10.1007/s13555-018-0265-y. Epub 2018 Oct 17. Dermatol Ther (Heidelb). 2018. PMID: 30334147 Free PMC article.
Safety and efficacy of intravenous bimagrumab in inclusion body myositis (RESILIENT): a randomised, double-blind, placebo-controlled phase 2b trial.
Hanna MG, Badrising UA, Benveniste O, Lloyd TE, Needham M, Chinoy H, Aoki M, Machado PM, Liang C, Reardon KA, de Visser M, Ascherman DP, Barohn RJ, Dimachkie MM, Miller JAL, Kissel JT, Oskarsson B, Joyce NC, Van den Bergh P, Baets J, De Bleecker JL, Karam C, David WS, Mirabella M, Nations SP, Jung HH, Pegoraro E, Maggi L, Rodolico C, Filosto M, Shaibani AI, Sivakumar K, Goyal NA, Mori-Yoshimura M, Yamashita S, Suzuki N, Katsuno M, Murata K, Nodera H, Nishino I, Romano CD, Williams VSL, Vissing J, Auberson LZ, Wu M, de Vera A, Papanicolaou DA, Amato AA; RESILIENT Study Group. Hanna MG, et al. Among authors: de vera a. Lancet Neurol. 2019 Sep;18(9):834-844. doi: 10.1016/S1474-4422(19)30200-5. Lancet Neurol. 2019. PMID: 31397289 Clinical Trial.
Sexual behaviour and poor hygiene are related to recent hepatitis a virus community outbreaks.
Hernández Bustabad A, Morales Arráez D, González A, de Vera A, Díaz-Flores F, Lecuona Fernández M, Gómez-Sirvent JL, Avellón Calvo A, Hernández-Guerra M. Hernández Bustabad A, et al. Among authors: de vera a. Rev Esp Enferm Dig. 2020 Jun;112(6):448-455. doi: 10.17235/reed.2020.6687/2019. Rev Esp Enferm Dig. 2020. PMID: 32450702 Free article.
Recent and historical pollution legacy in high altitude Lake Marboré (Central Pyrenees): A record of mining and smelting since pre-Roman times in the Iberian Peninsula.
Corella JP, Sierra MJ, Garralón A, Millán R, Rodríguez-Alonso J, Mata MP, de Vera AV, Moreno A, González-Sampériz P, Duval B, Amouroux D, Vivez P, Cuevas CA, Adame JA, Wilhelm B, Saiz-Lopez A, Valero-Garcés BL. Corella JP, et al. Among authors: de vera av. Sci Total Environ. 2021 Jan 10;751:141557. doi: 10.1016/j.scitotenv.2020.141557. Epub 2020 Aug 14. Sci Total Environ. 2021. PMID: 32882549
30 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page